|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q59675103
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010847.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q59675103
|
|
024
|
|
|
‡a
0000-0003-2178-9218
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q59675103
|
|
100
|
0 |
|
‡a
Marcelo N N Vieira
‡c
researcher ORCID ID = 0000-0003-2178-9218
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Marcelo N N Vieira
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhIAPP).
|
|
670
|
|
|
‡a
Author's Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
|
|
670
|
|
|
‡a
Author's Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure.
|
|
670
|
|
|
‡a
Author's Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra
|
|
670
|
|
|
‡a
Author's Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers
|
|
670
|
|
|
‡a
Author's Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer's Therapy?
|
|
670
|
|
|
‡a
Author's Small molecule inhibitors of lysozyme amyloid aggregation
|
|
670
|
|
|
‡a
Author's Soluble oligomers from a non-disease related protein mimic Abeta-induced tau hyperphosphorylation and neurodegeneration
|
|
670
|
|
|
‡a
Author's Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.
|
|
670
|
|
|
‡a
Author's Training Microglia to Resist Alzheimer's Disease
|
|
909
|
|
|
‡a
(orcid) 0000000321789218
‡9
1
|
|
919
|
|
|
‡a
trainingmicrogliatoresistalzheimersdisease
‡A
Training Microglia to Resist Alzheimer's Disease
‡9
1
|
|
919
|
|
|
‡a
solubleproteinoligomersasemergingtoxinsinalzheimersandotheramyloiddiseases
‡A
Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.
‡9
1
|
|
919
|
|
|
‡a
solubleoligomersfromanondiseaserelatedproteinmimicabetainducedtauhyperphosphorylationandneurodegeneration
‡A
Soluble oligomers from a non-disease related protein mimic Abeta-induced tau hyperphosphorylation and neurodegeneration
‡9
1
|
|
919
|
|
|
‡a
smallmoleculeinhibitorsoflysozymeamyloidaggregation
‡A
Small molecule inhibitors of lysozyme amyloid aggregation
‡9
1
|
|
919
|
|
|
‡a
proteintyrosinephosphatase1bptp1bapotentialtargetforalzheimerstherapy
‡A
Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer's Therapy?
‡9
1
|
|
919
|
|
|
‡a
protectionofsynapsesagainstalzheimerslinkedtoxinsinsulinsignalingpreventsthepathogenicbindingofabetaoligomers
‡A
Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers
‡9
1
|
|
919
|
|
|
‡a
monoaminetransporterinhibitorsandnorepinephrinereducedopaminedependentirontoxicityincellsderivedfromthesubstantianigra
‡A
Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra
‡9
1
|
|
919
|
|
|
‡a
formationofamyloidaggregatesfromhumanlysozymeanditsdiseaseassociatedvariantsusinghydrostaticpressure
‡A
Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure.
‡9
1
|
|
919
|
|
|
‡a
connectingalzheimersdiseasetodiabetesunderlyingmechanismsandpotentialtherapeutictargets
‡A
Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
‡9
1
|
|
919
|
|
|
‡a
amyloidogenicityandcytotoxicityofrecombinantmaturehumanisletamyloidpolypeptiderhiapp
‡A
Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhIAPP).
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
PTBNP|144209
|
|
996
|
|
|
‡2
ISNI|0000000043477088
|
|
996
|
|
|
‡2
SUDOC|081497733
|
|
996
|
|
|
‡2
BLBNB|000162903
|
|
996
|
|
|
‡2
LC|nb2004018202
|
|
996
|
|
|
‡2
BLBNB|000170647
|
|
996
|
|
|
‡2
SUDOC|249614707
|
|
996
|
|
|
‡2
BNC|981060745976406706
|
|
996
|
|
|
‡2
SUDOC|281603731
|
|
996
|
|
|
‡2
BLBNB|000390986
|
|
996
|
|
|
‡2
BLBNB|000402103
|
|
996
|
|
|
‡2
PTBNP|149808
|
|
996
|
|
|
‡2
LC|n 2017250499
|
|
996
|
|
|
‡2
ISNI|0000000068815872
|
|
996
|
|
|
‡2
NII|DA16124294
|
|
996
|
|
|
‡2
LC|n 2020250593
|
|
996
|
|
|
‡2
PTBNP|1513702
|
|
996
|
|
|
‡2
BLBNB|000493656
|
|
996
|
|
|
‡2
DNB|1147492905
|
|
996
|
|
|
‡2
BLBNB|000508241
|
|
996
|
|
|
‡2
BLBNB|001446344
|
|
996
|
|
|
‡2
PTBNP|1261782
|
|
996
|
|
|
‡2
ISNI|0000000068388225
|
|
996
|
|
|
‡2
DNB|1102918822
|
|
996
|
|
|
‡2
BLBNB|000325403
|
|
996
|
|
|
‡2
RERO|A023636138
|
|
996
|
|
|
‡2
PTBNP|531538
|
|
996
|
|
|
‡2
PTBNP|175956
|
|
996
|
|
|
‡2
DNB|1057047260
|
|
996
|
|
|
‡2
BLBNB|001644056
|
|
996
|
|
|
‡2
DNB|1219582042
|
|
996
|
|
|
‡2
LC|no2005009935
|
|
996
|
|
|
‡2
ISNI|0000000378911245
|
|
996
|
|
|
‡2
PTBNP|1627014
|
|
996
|
|
|
‡2
NSK|000279334
|
|
996
|
|
|
‡2
BLBNB|000332858
|
|
996
|
|
|
‡2
CAOONL|ncf11892831
|
|
996
|
|
|
‡2
LC|no2022061552
|
|
996
|
|
|
‡2
LC|no 93037258
|
|
996
|
|
|
‡2
ISNI|000000035852984X
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
